Health Affairs

Administration Releases Proposed Medicare International Drug Reference Pricing Models

CMS’s proposed GLOBE and GUARD models represent an evolution in the Trump Administration’s approach to international reference pricing. However, their operational differences underscore the ...
Forbes

From Patients To Consumers: Direct-To-Consumer Pricing As A Model For Healthcare Reform

Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...
Fierce Healthcare

CMMI proposes new models to lower drug prices to international rates for Medicare Parts B, D

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.
Healthcare Dive

The case for transparent pricing: Making pharmacy benefits work for health plans

Health plans are critical to transforming health care, making it more personal, accessible and affordable. Transparency is at the core of this transformation, with health plans driving value-based ...
JD Supra

CMS Releases MFN Drug Pricing Models for Medicare Parts B and D and Medicaid Amid Trump Administration’s Push for Direct-to-Consumer Strategy

On December 19, 2025, the Centers for Medicare & Medicaid Services (CMS) released GLOBE (Global Benchmark for Efficient Drug Pricing Model) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) ...